Search

everythinglearnresearchcommunity

for

Search:↓

Stem cells and their secretions could potentially treat stress-induced hair loss, but more human trials are needed.

Symmetrical Acrokeratoderma (SAK) may be a unique skin condition in China, lacking specific treatment and needing long-term monitoring.

Transfollicular drug delivery is promising but needs more research to improve and understand it better.

Nanoparticles can be used to deliver drugs to hair follicles, potentially improving treatments for conditions like acne and alopecia, and could also be used for vaccine delivery and gene therapy.

Innate lymphoid cells type 1 may contribute to alopecia areata by damaging hair follicles.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

Pica disorder in central Iraq is mainly found in females and is linked to low iron levels; treatment with iron improves most patients.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Contact immunotherapy can cause vitiligo in patients with autoimmune conditions.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

2-deoxy D-glucose does not help with hair regrowth in alopecia areata.

Liquid nitrogen cryotherapy and betamethasone lotion are equally effective for treating alopecia areata.

Mice treatments didn't grow hair, a patient treatment may affect immune response, and people with hair loss often feel anxious or depressed.

Deleting Snai2 and Snai3 causes fatal autoimmunity.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Skin aging is due to impaired stem cell mobilization or fewer responsive stem cells.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Different types of stem cells exist within individual skin layers, and they can adapt to damage, transplantation, or tumor growth. These cells are regulated by their environment and genetic factors. Tumor growth is driven by expanding, genetically altered cells, not long-lived mutant stem cells. There's evidence of cancer stem cells in skin tumors. Other cells, bacteria, and genetic factors help maintain balance and contribute to disease progression. A method for growing mini organs from single cells has been developed.

Skin fat helps with body temperature control and has other active roles in health.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Toll-like receptors are important for wound healing, but can slow it down in diabetic wounds.

Both mouse and rat models are effective for testing alopecia areata treatments.

Brain hormones significantly affect hair color and could potentially be used to prevent or reverse grey hair.